Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts
Clinical trial NCT04649541 · COMPLETED
Trial details
- NCT number
- NCT04649541
- Sponsor
- MicuRx
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-29
- Primary completion
- 2021-12-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.